Roger Smith

Roger Smith joined Signant Health as Chief Executive Officer to guide the company during an exciting time of evolution and growth. Roger is focused on realizing the company’s immense unlocked value by leading customers to aggressive adoption of eCOA, IRT, and Endpoint Solutions individually, as a platform to future direct-to-patient trial conduct. His vision is for Signant to lead the industry through product roadmap priorities, customer service excellence, commercial expansion, and most importantly, coming together as one culture around these principles. Roger joins Signant from PPD, where he was Senior Vice President and General Manager of Accelerated Enrollment Solutions (AES), which offers biopharmaceutical sponsors and contract research organizations best-in-class clinical trial site conduct and patient access solutions. In his role, he was responsible for AES’s strategic direction and financial growth as its chief executive, and played a pivotal role working closely with research sites and pharmaceutical organizations to solve patient recruitment challenges by utilizing digital technology and data science. Prior to joining PPD in 2013 through its acquisition of Acurian, Mr. Smith held a number of senior management positions for Acurian, Kozmo.com and Sony Corporation. Roger brings decades of experience to the company and has a proven record of taking customer-centric technology and solutions companies like Signant Health to the next level by expanding the market for their services.